日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [(111)In]In-Radioligands: Synthesis and Preclinical Profile

双(二硫键)桥联生长抑素-14类似物及其[(111)In]In放射性配体:合成和临床前研究

Tatsi, Aikaterini; Maina, Theodosia; Waser, Beatrice; Krenning, Eric P; de Jong, Marion; Reubi, Jean Claude; Cordopatis, Paul; Nock, Berthold A

Improved Localization of Insulinomas Using (68)Ga-NODAGA-Exendin-4 PET/CT

使用 (68)Ga-NODAGA-Exendin-4 PET/CT 改进胰岛素瘤的定位

Boss, Marti; Eriksson, Olof; Mikkola, Kirsi; Eek, Annemarie; Brom, Maarten; Buitinga, Mijke; Brouwers, Adrienne H; Velikyan, Irina; Waser, Beatrice; Kauhanen, Saila; Solin, Olof; Marciniak, Camille; Eriksson, Barbro; Reubi, Jean-Claude; Aveline, Cyrielle; Wild, Damian; Pattou, Francois; Talbot, Jean-Noel; Hofland, Johannes; Sundin, Anders; Nuutila, Pirjo; Hermans, John; Gotthardt, Martin

AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients

对第一代生长抑素类似物耐药的AIP突变肢端肥大症:两例患者使用帕瑞肽LAR可实现长期控制

Daly, Adrian F; Rostomyan, Liliya; Betea, Daniela; Bonneville, Jean-François; Villa, Chiara; Pellegata, Natalia S; Waser, Beatrice; Reubi, Jean-Claude; Waeber Stephan, Catherine; Christ, Emanuel; Beckers, Albert

The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist

在新型锝-99m标记的生长抑素受体2拮抗剂中,四胺螯合剂的性能优于HYNIC。

Abiraj, Keelara; Ursillo, Samer; Tamma, Maria Luisa; Rylova, Svetlana N; Waser, Beatrice; Constable, Edwin C; Fani, Melpomeni; Nicolas, Guillaume P; Reubi, Jean Claude; Maecke, Helmut R

Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist--from mice to men

利用胃泌素释放肽受体拮抗剂进行前列腺癌正电子发射断层扫描(PET)成像——从动物模型到临床研究

Wieser, Gesche; Mansi, Rosalba; Grosu, Anca L; Schultze-Seemann, Wolfgang; Dumont-Walter, Rebecca A; Meyer, Philipp T; Maecke, Helmut R; Reubi, Jean Claude; Weber, Wolfgang A

Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors

在小鼠神经内分泌肿瘤模型中,肽受体靶向俄歇电子放射疗法与抗血管生成化合物的协同作用

Wicki, Andreas; Wild, Damian; Prêtre, Vincent; Mansi, Rosalba; Orleth, Annette; Reubi, Jean-Claude; Rochlitz, Christoph; Mamot, Christoph; Mäcke, Helmut R; Christofori, Gerhard

Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications

癌症中胰高血糖素样肽-1受体的过度表达及其对临床应用的影响

Körner, Meike; Christ, Emanuel; Wild, Damian; Reubi, Jean Claude

[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study

[111In-DOTA]生长抑素-14类似物作为潜在的泛生长抑素样放射性示踪剂——临床前研究的初步结果

Tatsi, Aikaterini; Maina, Theodosia; Cescato, Renzo; Waser, Beatrice; Krenning, Eric P; de Jong, Marion; Cordopatis, Paul; Reubi, Jean Claude; Nock, Berthold A

Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides

12种¹¹¹In标记的胃泌素/CCK2受体靶向肽的生物分布比较

Laverman, Peter; Joosten, Lieke; Eek, Annemarie; Roosenburg, Susan; Peitl, Petra Kolenc; Maina, Theodosia; Mäcke, Helmut; Aloj, Luigi; von Guggenberg, Elisabeth; Sosabowski, Jane K; de Jong, Marion; Reubi, Jean-Claude; Oyen, Wim J G; Boerman, Otto C

Conformationally homogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues

构象均一的杂环假四肽作为合理药物设计的三维支架:受体选择性生长抑素类似物

Beierle, John M; Horne, W Seth; van Maarseveen, Jan H; Waser, Beatrice; Reubi, Jean Claude; Ghadiri, M Reza